These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 32588493)

  • 1. COVID-19-Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches.
    Sorokin AV; Karathanasis SK; Yang ZH; Freeman L; Kotani K; Remaley AT
    FASEB J; 2020 Aug; 34(8):9843-9853. PubMed ID: 32588493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of HDL mimetic peptide 4F on PON1.
    Vakili L; Hama S; Kim JB; Tien D; Safarpoor S; Ly N; Vakili G; Hough G; Navab M
    Adv Exp Med Biol; 2010; 660():167-72. PubMed ID: 20221879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro resolving inflammatory effects of the lipid mediators of omega 3 fatty acids and its implication in SARS COVID-19.
    Regidor PA; Santos FG; Rizo JM; Egea FM
    Med Hypotheses; 2020 Dec; 145():110340. PubMed ID: 33069094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease.
    Vaziri ND
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S35-43. PubMed ID: 20797569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifaced Roles of HDL in Sepsis and SARS-CoV-2 Infection: Renal Implications.
    Stasi A; Franzin R; Fiorentino M; Squiccimarro E; Castellano G; Gesualdo L
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein Mimetic Peptides: An Emerging Therapy against Diabetic Inflammation and Dyslipidemia.
    Wolkowicz P; White CR; Anantharamaiah GM
    Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33922449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro- or anti-inflammatory role of apolipoprotein A-1 in high-density lipoproteins?
    Vuilleumier N; Dayer JM; von Eckardstein A; Roux-Lombard P
    Swiss Med Wkly; 2013; 143():w13781. PubMed ID: 23740387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ AFM imaging of apolipoprotein A-I directly derived from plasma HDL.
    Gan C; Wang Z; Chen Y
    Atherosclerosis; 2017 Apr; 259():5-11. PubMed ID: 28279834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High density lipoprotein structure-function and role in reverse cholesterol transport.
    Lund-Katz S; Phillips MC
    Subcell Biochem; 2010; 51():183-227. PubMed ID: 20213545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidized Lipids and Lipoprotein Dysfunction in Psoriasis.
    Sorokin AV; Remaley AT; Mehta NN
    J Psoriasis Psoriatic Arthritis; 2020 Oct; 5(4):139-146. PubMed ID: 33163854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of high-density lipoprotein in inflammation.
    Navab M; Anantharamaiah GM; Fogelman AM
    Trends Cardiovasc Med; 2005 May; 15(4):158-61. PubMed ID: 16099381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures of apolipoprotein A-I in high density lipoprotein generated by electron microscopy and biased simulations.
    Zhu L; Petrlova J; Gysbers P; Hebert H; Wallin S; Jegerschöld C; Lagerstedt JO
    Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2726-2738. PubMed ID: 28754383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Density Lipoprotein Nanobiologics for Precision Medicine.
    Mulder WJM; van Leent MMT; Lameijer M; Fisher EA; Fayad ZA; Pérez-Medina C
    Acc Chem Res; 2018 Jan; 51(1):127-137. PubMed ID: 29281244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of apolipoprotein-specific high-density lipoprotein particles from lipid-free apolipoproteins A-I and A-II.
    Clay MA; Cehic DA; Pyle DH; Rye KA; Barter PJ
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):445-51. PubMed ID: 9895287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that phospholipids play a key role in pre-beta apoA-I formation and high-density lipoprotein remodeling.
    Rye KA; Duong M; Psaltis MK; Curtiss LK; Bonnet DJ; Stocker R; Barter PJ
    Biochemistry; 2002 Oct; 41(41):12538-45. PubMed ID: 12369845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.
    Kontush A; Chapman MJ
    Pharmacol Rev; 2006 Sep; 58(3):342-74. PubMed ID: 16968945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice.
    Chroni A; Kan HY; Kypreos KE; Gorshkova IN; Shkodrani A; Zannis VI
    Biochemistry; 2004 Aug; 43(32):10442-57. PubMed ID: 15301543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of genetic deletion of platform apolipoproteins on the size distribution of the murine lipoproteome.
    Gordon SM; Li H; Zhu X; Tso P; Reardon CA; Shah AS; Lu LJ; Davidson WS
    J Proteomics; 2016 Sep; 146():184-94. PubMed ID: 27385375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of High-Density Lipoprotein in COVID-19.
    Wang G; Deng J; Li J; Wu C; Dong H; Wu S; Zhong Y
    Front Pharmacol; 2021; 12():720283. PubMed ID: 34335279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I.
    Rye KA; Barter PJ
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):421-8. PubMed ID: 14592845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.